Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment

Targeting the immune checkpoint receptors cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death 1 ligand 1 (PD-L1) represents a very attractive treatment modality for tumor patients. The administration of antibodies against these receptors can pr...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines
Main Authors: Tunger, Antje, Kießler, Maximilian, Wehner, Rebekka, Temme, Achim, Meier, Friedegund, Bachmann, Michael, Schmitz, Marc
Format: Artigo
Language:Inglês
Published: MDPI 2018
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5874683/
https://ncbi.nlm.nih.gov/pubmed/29494517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines6010026
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items